Phosphoinositide 3-Kinases γ and δ, Linkers of Coordinate C5a Receptor-Fcγ Receptor Activation and Immune Complex-induced Inflammation*
暂无分享,去创建一个
E. Hirsch | B. Nürnberg | R. Schmidt | R. Piekorz | J. E. Gessner | S. Syed | S. Konrad | K. Wiege | S. R. Ali | Linda Engling | J. Gessner
[1] T. Diacovo,et al. Role of PI3Kδ and PI3Kγ in inflammatory arthritis and tissue localization of neutrophils , 2008, European journal of immunology.
[2] E. Hirsch,et al. Targeting phosphoinositide 3-kinase γ to fight inflammation and more , 2008, Thrombosis and Haemostasis.
[3] R. Schmidt,et al. Characterization of the Murine IgG Fc Receptor III and IIB Gene Promoters , 2007, Journal of Biological Chemistry.
[4] D. Aronoff,et al. Activation of Phosphatase and Tensin Homolog on Chromosome 10 Mediates the Inhibition of FcγR Phagocytosis by Prostaglandin E2 in Alveolar Macrophages1 , 2007, The Journal of Immunology.
[5] M. Camps,et al. The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion. , 2007, Blood.
[6] K. Okkenhaug,et al. Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation. , 2007, Blood.
[7] P. Monk,et al. Function, structure and therapeutic potential of complement C5a receptors , 2007, British journal of pharmacology.
[8] S. Ward,et al. Phosphoinositide 3‐kinase signalling in lung disease: leucocytes and beyond , 2007, Immunology.
[9] C. Rommel,et al. PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond? , 2007, Nature Reviews Immunology.
[10] K. Okkenhaug,et al. Requirement for Phosphoinositide 3-Kinase p110δ Signaling in B Cell Antigen Receptor-Mediated Antigen Presentation1 , 2007, The Journal of Immunology.
[11] K. Okkenhaug,et al. Role of the phosphoinositide 3‐kinase p110δ in generation of type 2 cytokine responses and allergic airway inflammation , 2007, European journal of immunology.
[12] John D Lambris,et al. Generation of C5a in the absence of C3: a new complement activation pathway , 2006, Nature Medicine.
[13] R. Schmidt,et al. Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice. , 2006, The Journal of clinical investigation.
[14] R. Schmidt,et al. Fc receptors and their interaction with complement in autoimmunity. , 2005, Immunology letters.
[15] D. Eslin,et al. The relative role of PLCbeta and PI3Kgamma in platelet activation. , 2005, Blood.
[16] P. Finan,et al. Airway inflammation: chemokine‐induced neutrophilia and the class I phosphoinositide 3‐kinases , 2005, European journal of immunology.
[17] L. Birnbaumer,et al. Macrophages Induce the Inflammatory Response in the Pulmonary Arthus Reaction through Gαi2 Activation That Controls C5aR and Fc Receptor Cooperation1 , 2005, The Journal of Immunology.
[18] P. Finan,et al. Essential role for the p110δ phosphoinositide 3-kinase in the allergic response , 2004, Nature.
[19] C. Garlanda,et al. Defective dendritic cell migration and activation of adaptive immunity in PI3Kγ‐deficient mice , 2004 .
[20] T. Graf,et al. Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue. , 2004, Blood.
[21] S. Koyasu. The role of PI3K in immune cells , 2003, Nature Immunology.
[22] J. Ihle,et al. Essential, Nonredundant Role for the Phosphoinositide 3-Kinase p110δ in Signaling by the B-Cell Receptor Complex , 2002, Molecular and Cellular Biology.
[23] E. Vigorito,et al. A Crucial Role for the p110δ Subunit of Phosphatidylinositol 3-Kinase in B Cell Development and Activation , 2002, The Journal of experimental medicine.
[24] T. Takai. Roles of Fc receptors in autoimmunity , 2002, Nature Reviews Immunology.
[25] P. Heeringa,et al. Opposite Regulation of Type II and III Receptors for Immunoglobulin G in Mouse Glomerular Mesangial Cells and in the Induction of Anti-glomerular Basement Membrane (GBM) Nephritis* , 2002, The Journal of Biological Chemistry.
[26] K. Okkenhaug,et al. Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice , 2002, Science.
[27] P. Finan,et al. Phosphoinositide 3-Kinase γ Is an Essential Amplifier of Mast Cell Function , 2002 .
[28] Ralph Weissleder,et al. Arthritis critically dependent on innate immune system players. , 2002, Immunity.
[29] L. Cantley,et al. Phosphoinositide 3-kinase in immunological systems. , 2002, Seminars in immunology.
[30] B. Nieswandt,et al. FcγRIII-Mediated Production of TNF-α Induces Immune Complex Alveolitis Independently of CXC Chemokine Generation1 , 2001, The Journal of Immunology.
[31] K. Okkenhaug,et al. PI3K-signalling in B- and T-cells: insights from gene-targeted mice. , 2001, Biochemical Society transactions.
[32] Dianqing Wu,et al. Roles of PLC-β2 and -β3 and PI3Kγ in Chemoattractant-Mediated Signal Transduction , 2000 .
[33] W L Stanford,et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. , 2000, Science.
[34] Silvano Sozzani,et al. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation , 2000 .
[35] R. Schmidt,et al. Mouse FcγRII is a negative regulator of FcγRIII in IgG immune complex‐triggered inflammation but not in autoantibody‐induced hemolysis , 2000 .
[36] L Matis,et al. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. , 1999, Circulation.
[37] F. Alt,et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. , 1999, Science.
[38] Y. Yazaki,et al. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. , 1999, Science.
[39] L. Pirola,et al. Structure and function of phosphoinositide 3-kinases. , 1998, Biochimica et biophysica acta.
[40] B. Morgan. The Human Complement System in Health and Disease. , 1998 .
[41] L. Matis,et al. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. , 1998, Circulation.
[42] U. Höpken,et al. Impaired Inflammatory Responses in the Reverse Arthus Reaction Through Genetic Deletion of the C5a Receptor , 1997, The Journal of experimental medicine.
[43] T. Raffin,et al. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. , 1986, The Journal of clinical investigation.
[44] J. Volanakis. The human complement system. , 1975, Journal of oral pathology.
[45] Bernd Giese,et al. Targeting phosphoinositide 3-kinase: moving towards therapy. , 2008, Biochimica et biophysica acta.
[46] J. Ravetch,et al. Fcgamma receptors: old friends and new family members. , 2006, Immunity.
[47] John F. Timms,et al. Cellular function of phosphoinositide 3-kinases: Implications for development, immunity, homeostasis, and cancer , 2001 .
[48] J. V. Ravetch,et al. IgG Fc receptors. , 2001, Annual review of immunology.
[49] J. Kinet,et al. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. , 1999 .